Filter announcements
Loading...
Founded in June 1998, Quest Laboratories Limited produces a diverse range of pharmaceuticals, including antibiotics, antimalarials, anti-inflammatories, etc.
Quest Laboratories clarified a submission error, providing revised financial results to include the previously missed full-year figures for March 31, 2025. This correction ensures complete disclosure for investors.
Auditors noted insufficient records for inventory valuation. However, management confirmed physical checks found no material discrepancies, and this did not change the auditor's unmodified opinion on the financial results. Figures remain as presented.
Quest Laboratories has submitted its Statement of Investor Grievance & Redressal Mechanism for the quarter ending December 31, 2024. The report indicates no pending complaints, with all issues resolved during this period. This proactive approach suggests strong management focus on customer satisfaction and maintaining investor trust. This clear grievance status...